INFLUENCE OF DESGLYCINAMIDE-(ARG8) VASOPRESSIN ON MEMORY IN HEALTHY-SUBJECTS

被引:13
作者
BRUINS, J [1 ]
KUMAR, A [1 ]
SCHNEIDERHELMERT, D [1 ]
机构
[1] UNIV AMSTERDAM,DEPT PSYCHOL,AMSTERDAM,NETHERLANDS
关键词
DESGLYCINAMIDE-(ARG8) VASOPRESSIN; MEMORY; ATTENTION; MOOD;
D O I
10.1159/000119432
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In 12 healthy student volunteers the influence on memory, attention and mood of a single dose of 12 mg of the vasopressin analog, desglycinamide-(arg8) vasopressin (DGAVP), given by the nasal route was investigated. On day 1 all subjects received placebo (single-blind), 1 week later they were given either DGAVP or placebo (double-blind). Memory effects were measured with the Buschke restrictive reminding method. DGAVP significantly improved storage processes, with retrieval processes less affected. Attention and mood processes were not influenced. It is suggested that DGAVP has an influence on memory processes.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 39 条
[1]  
BAILEY WH, 1982, CHANGING CONCEPTS NE, P787
[2]   VASOPRESSIN ANALOG (DDAVP) IMPROVES MEMORY IN HUMAN MALES [J].
BECKWITH, BE ;
TILL, RE ;
SCHNEIDER, V .
PEPTIDES, 1984, 5 (04) :819-822
[3]   VASOPRESSIN ANALOG INFLUENCES THE PERFORMANCE OF MALES ON A REACTION-TIME-TASK [J].
BECKWITH, BE ;
COUK, DI ;
TILL, TS .
PEPTIDES, 1983, 4 (05) :707-709
[4]   EFFECTS OF VASOPRESSIN ON ACTIVE AND PASSIVE AVOIDANCE BEHAVIOR [J].
BOHUS, B ;
ADER, R ;
WIED, DD .
HORMONES AND BEHAVIOR, 1972, 3 (03) :191-&
[5]   VASOPRESSIN (DDAVP) THERAPY IN CHRONIC-SCHIZOPHRENIA - EFFECTS ON NEGATIVE SYMPTOMS AND MEMORY [J].
BRAMBILLA, F ;
BONDIOLOTTI, GP ;
MAGGIONI, M ;
SCIASCIA, A ;
GRILLO, W ;
SANNA, F ;
LATINA, A ;
PICOTTI, GB .
NEUROPSYCHOBIOLOGY, 1988, 20 (03) :113-119
[7]   EVALUATING STORAGE, RETENTION, AND RETRIEVAL IN DISORDERED MEMORY AND LEARNING [J].
BUSCHKE, H ;
FULD, PA .
NEUROLOGY, 1974, 24 (11) :1019-1025
[8]   SPONTANEOUS REMEMBERING AFTER RECALL FAILURE [J].
BUSCHKE, H .
SCIENCE, 1974, 184 (4136) :579-581
[9]   EFFECTS OF DESMOPRESSIN ACETATE (DDAVP) ON THE LEARNING OF A BRIGHTNESS-DISCRIMINATION [J].
COUK, DI ;
BECKWITH, BE .
PEPTIDES, 1982, 3 (03) :521-526
[10]  
De WIED D., 1965, INT J NEUROPHARMACOL, V4, P157